Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
34180 | 76 | 26.5 | 66% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | GROWTH FACTOR DEPRIVATION THERAPY | Author keyword | 3 | 100% | 4% | 3 |
2 | A63162 | Author keyword | 1 | 50% | 1% | 1 |
3 | MED DISCOVERY | Address | 1 | 50% | 1% | 1 |
4 | PC3 PROLIFERATION | Author keyword | 1 | 50% | 1% | 1 |
5 | T98G GLIOBLASTOMA | Author keyword | 1 | 50% | 1% | 1 |
6 | CELL PROLIFERATIONS | Author keyword | 0 | 33% | 1% | 1 |
7 | FREE RADICAL SPIN TRAP | Author keyword | 0 | 33% | 1% | 1 |
8 | UMR 1698 | Address | 0 | 33% | 1% | 1 |
9 | ETYA | Author keyword | 0 | 17% | 3% | 2 |
10 | ANTISENSE BCL 2 | Author keyword | 0 | 25% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | GROWTH FACTOR DEPRIVATION THERAPY | 3 | 100% | 4% | 3 | Search GROWTH+FACTOR+DEPRIVATION+THERAPY | Search GROWTH+FACTOR+DEPRIVATION+THERAPY |
2 | A63162 | 1 | 50% | 1% | 1 | Search A63162 | Search A63162 |
3 | PC3 PROLIFERATION | 1 | 50% | 1% | 1 | Search PC3+PROLIFERATION | Search PC3+PROLIFERATION |
4 | T98G GLIOBLASTOMA | 1 | 50% | 1% | 1 | Search T98G+GLIOBLASTOMA | Search T98G+GLIOBLASTOMA |
5 | CELL PROLIFERATIONS | 0 | 33% | 1% | 1 | Search CELL+PROLIFERATIONS | Search CELL+PROLIFERATIONS |
6 | FREE RADICAL SPIN TRAP | 0 | 33% | 1% | 1 | Search FREE+RADICAL+SPIN+TRAP | Search FREE+RADICAL+SPIN+TRAP |
7 | ETYA | 0 | 17% | 3% | 2 | Search ETYA | Search ETYA |
8 | ANTISENSE BCL 2 | 0 | 25% | 1% | 1 | Search ANTISENSE+BCL+2 | Search ANTISENSE+BCL+2 |
9 | HUMAN PANCREATIC CANCER CELLS | 0 | 13% | 1% | 1 | Search HUMAN+PANCREATIC+CANCER+CELLS | Search HUMAN+PANCREATIC+CANCER+CELLS |
10 | BCL 2 THERAPY | 0 | 100% | 1% | 1 | Search BCL+2+THERAPY | Search BCL+2+THERAPY |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | AUTOCRINE REGULATED GROWTH | 14 | 100% | 9% | 7 |
2 | HORMONE INSENSITIVE PROSTATE | 6 | 80% | 5% | 4 |
3 | 5 8 11 14 EICOSATETRAYNOIC ACID | 2 | 28% | 9% | 7 |
4 | MULTIPLE BINDING SITES | 2 | 29% | 8% | 6 |
5 | ENHANCE CHEMOSENSITIVITY | 1 | 50% | 1% | 1 |
6 | GROWTH PATHWAY | 1 | 50% | 1% | 1 |
7 | SHIONOGI TUMOR MODEL | 0 | 11% | 3% | 2 |
8 | ANDROGEN INDEPENDENT PROGRESSION | 0 | 10% | 1% | 1 |
9 | 13 ACETATE INDUCED DIFFERENTIATION | 0 | 100% | 1% | 1 |
10 | BISPECIFIC ANTISENSE OLIGONUCLEOTIDES | 0 | 100% | 1% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
A review of antisense oligonucleotides in the treatment of human disease | 2004 | 16 | 47 | 13% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MED DISCOVERY | 1 | 50% | 1.3% | 1 |
2 | UMR 1698 | 0 | 33% | 1.3% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000156041 | TMEM132A//C FOS SERUM RESPONSE ELEMENT//FAS FASL INTERACTIONS |
2 | 0.0000126810 | LARREA DIVARICATA CAV//NDGA//NORDIHYDROGUAIARETIC ACID |
3 | 0.0000124169 | INTERCAMPUS PROGRAM MOL BIOPHYS//PLANT MELANIN//WBSB |
4 | 0.0000094653 | CYSPLATIN//FLUORESCENT METHODS//ADRIABLASTIN |
5 | 0.0000086299 | MED PHYSIOL UNIT//GAMMA LINOLENIC ACID//YORKSHIRE EXPT CANC MED |
6 | 0.0000086009 | 5 LIPOXYGENASE//LEUKOTRIENE A4 HYDROLASE//5 LIPOXYGENASE ACTIVATING PROTEIN |
7 | 0.0000080732 | BCL 2//BCL 2 PROTEIN//BCL X |
8 | 0.0000079087 | RETRODIFFERENTIATION//BIOCHEM TUMOR BIOL//BIOCHEM TUMOR BIOL OE6411 |
9 | 0.0000076848 | LEUKOTRIENE C 4 SYNTHESIS DEFICIENCY//HADASSAH MED PHARMACOL//EICOSATETRAYNOIC ACID |
10 | 0.0000064696 | CYCLOPENTENONE PROSTAGLANDINS//DELTA12 PROSTAGLANDIN J2//DELTA 12 PROSTAGLANDIN J2 |